Company profile
Roivant Sciences Ltd. insider acquisitions
Company CIK 0001635088 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 22, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
26 dated transactions · 8 of 9 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | Roivant Sciences Ltd.Common Shares | Epperly Melissa B, | Exercise / conversion |
| Sep 30, 2026 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Sep 30, 2026 | Roivant Sciences Ltd.Common Shares | Torti Frank | Other acquisition |
| Dec 31, 2025 | Roivant Sciences Ltd.Common Shares | Sukhatme Mayukh | Exercise / conversion |
| Dec 29, 2025 | Roivant Sciences Ltd.Common Shares | Sukhatme Mayukh | Exercise / conversion |
| Dec 23, 2025 | Roivant Sciences Ltd.Common Shares | Torti Frank | Stock award |
| Dec 23, 2025 | Roivant Sciences Ltd.Common Shares | Pulik Richard | Exercise / conversion |
| Dec 24, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Dec 23, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Dec 17, 2025 | Roivant Sciences Ltd.Common Shares | Sukhatme Mayukh | Exercise / conversion |
| Dec 15, 2025 | Roivant Sciences Ltd.Common Shares | Gline Matthew | Exercise / conversion |
| Dec 15, 2025 | Roivant Sciences Ltd.Common Shares | Gline Matthew | Exercise / conversion |
| Dec 15, 2025 | Roivant Sciences Ltd.Common Shares | Gline Matthew | Exercise / conversion |
| Dec 15, 2025 | Roivant Sciences Ltd.Common Shares | Ramaswamy Vivek | Exercise / conversion |
| Dec 12, 2025 | Roivant Sciences Ltd.Common Shares | Ramaswamy Vivek | Exercise / conversion |
| Dec 11, 2025 | Roivant Sciences Ltd.Common Shares | Ramaswamy Vivek | Exercise / conversion |
| Dec 9, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Nov 7, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Oct 20, 2025 | Roivant Sciences Ltd.Common Shares | Epperly Melissa B, | Stock award |
| Oct 20, 2025 | Roivant Sciences Ltd.Common Shares | MOMTAZEE JAMES C | Stock award |
| Oct 20, 2025 | Roivant Sciences Ltd.Common Shares | Oren Ilan | Stock award |
| Oct 17, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Oct 16, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Oct 15, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Oct 13, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
| Oct 9, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
ROIV · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Epperly Melissa B,Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 17,750 | 4.46Value: 79,165Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 200,000 | 3.85Value: 770,000Currency not specified | View ↗ |
| Trade: | Torti FrankPresident and Vant Chair | Other acquisitionCommon SharesNon-derivative security · Code F | 40,309 | 36.57Value: 1,474,100.13Currency not specified | View ↗ |
| Trade: | Sukhatme MayukhPresident & CIO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 2,449,877 | 12.68Value: 31,064,440.36Currency not specified | View ↗ |
| Trade: | Sukhatme MayukhPresident & CIO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 748,358 | 12.68Value: 9,489,179.44Currency not specified | View ↗ |
| Trade: | Torti FrankPresident and Vant Chair | Stock awardCommon SharesNon-derivative security · Code A | 175,380 | 22.45 *Value: 3,937,281Currency not specified | View ↗ |
| Trade: | Exercise / conversionCommon SharesNon-derivative security · Code M | 260,000 | 3.85Value: 1,001,000Currency not specified | View ↗ | |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 117,848 | 3.85Value: 453,714.8Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 313,841 | 3.85Value: 1,208,287.85Currency not specified | View ↗ |
| Trade: | Sukhatme MayukhPresident & CIO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 59,513 | 12.68Value: 754,624.84Currency not specified | View ↗ |
| Trade: | Gline MatthewCEO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 2,272,852 | 12.68Value: 28,819,763.36Currency not specified | View ↗ |
| Trade: | Gline MatthewCEO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 1,363,711 | 12.68Value: 17,291,855.48Currency not specified | View ↗ |
| Trade: | Gline MatthewCEO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 234,096 | 4.06Value: 950,429.76Currency not specified | View ↗ |
| Trade: | Ramaswamy Vivek10% owner | Exercise / conversionCommon SharesNon-derivative security · Code M | 832,453 | 12.68Value: 10,555,504.04Currency not specified | View ↗ |
| Trade: | Ramaswamy Vivek10% owner | Exercise / conversionCommon SharesNon-derivative security · Code M | 4,672,724 | 12.68Value: 59,250,140.32Currency not specified | View ↗ |
| Trade: | Ramaswamy Vivek10% owner | Exercise / conversionCommon SharesNon-derivative security · Code M | 1,869,691 | 12.68Value: 23,707,681.88Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 200,000 | 3.85Value: 770,000Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 200,000 | 3.85Value: 770,000Currency not specified | View ↗ |
| Trade: | Epperly Melissa B,Director | Stock awardCommon SharesNon-derivative security · Code A | 1,056 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | MOMTAZEE JAMES CDirector | Stock awardCommon SharesNon-derivative security · Code A | 789 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | Oren IlanDirector | Stock awardCommon SharesNon-derivative security · Code A | 1,507 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 118,418 | 15.85Value: 1,876,925.3Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 318,282 | 15.85Value: 5,044,769.7Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 414,683 | 15.85Value: 6,572,725.55Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 20,727 | 15.85Value: 328,522.95Currency not specified | View ↗ |
| Trade: | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 104,940 | 15.85Value: 1,663,299Currency not specified | View ↗ |
26 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →